Nuzenio

Phase Ib

Phase Ib news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 7 latest news signals 7 publisher sources 100/100 entity strength

Latest news

Timeline

Wed, 05 Aug 2026 14:32:11 GMTPhase I Trial Evaluates Allogeneic CD70-Targeted CAR T-Cell Therapy in Advanced Renal Cell Carcinoma - The ASCO Post
Wed, 05 Aug 2026 12:22:00 GMTTourette drug candidate enters Phase IIb with prior 21% tic reduction - Stock Titan
Wed, 05 Aug 2026 10:22:34 GMTEvexta Bio and Roche plan Phase Ib trial of rupitasertib with giredestrant - Clinical Trials Arena
Mon, 03 Aug 2026 07:00:00 GMTUmecrine Cognition includes final patient in Phase Ib/IIa study - Biostock
Tue, 28 Jul 2026 06:56:04 GMTAkeso Doses First Patient in AK138D1 + Ivonescimab Phase Ib/II Lung Cancer Study - The Clinical Trial Vanguard
Mon, 27 Jul 2026 15:32:36 GMTRaffaele Colombo: Phase 1b Trial Results of Iza-Bren in Extensive-Stage SCLC - oncodaily.com

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Phase Ib.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

7 distinct publisher/source names are currently connected to this entity page.